Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide notice informs users about potential delays due to a lapse in government funding and notes that the NIH Clinical Center is open, and the revision tag has been updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:52.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Additions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:45:27.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Location details updated: New York and Washington sites added; related location sections adjusted and the HHS disclosure link removed (revision v3.3.3).
    Difference
    0.3%
    Check dated 2025-12-23T09:55:18.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:18.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice from the page, including references to cc.nih.gov and opm.gov. This notice previously informed users about potential delays in updates; its removal does not affect the study details presented.
    Difference
    0.4%
    Check dated 2025-11-17T18:01:55.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.